farmaco

Palopegteriparatide: New Hormone Replacement Therapy for Chronic Hypoparathyroidism in Adults

by

Palopegteriparatide has emerged as a significant development in the management of chronic hypoparathyroidism, a rare endocrine disorder characterized by insufficient parathyroid hormone (PTH) production. Following recent regulatory approvals, this once-daily subcutaneous injection offers a targeted replacement therapy for adults struggling to maintain stable calcium and phosphate levels through conventional treatments. As a physician, I have … Read more

Experimental Drug Successfully Suppresses Virus to Undetectable Levels in Clinical Trials

by

An experimental therapeutic vaccine, known as bepirovirsen, has shown potential in achieving a “functional cure” for chronic hepatitis B, according to results published in the New England Journal of Medicine. Clinical trials indicate that approximately 1 in 5 patients treated with the investigational drug maintained low levels of the hepatitis B virus (HBV) after treatment, … Read more

Daraxonrasib: Experimental Oral Drug Could Transform Second-Line Cancer Treatment

by

As we continue to monitor advancements in oncology, a significant development has emerged regarding the treatment landscape for metastatic pancreatic ductal adenocarcinoma (PDAC). The U.S. Food and Drug Administration (FDA) has recently taken steps to facilitate access to an experimental therapy, daraxonrasib (also known as RMC-6236), which is currently under investigation for its potential to … Read more

Experimental Drug Shows Promise for Lung Cancer with Brain Metastases

by

As we continue to navigate the complexities of oncology, one of the most persistent challenges remains the treatment of non-small cell lung cancer (NSCLC) that has progressed to the brain. Metastasis to the central nervous system significantly complicates therapeutic strategies, often limiting the efficacy of traditional systemic treatments due to the restrictive nature of the … Read more

Multiple Myeloma Breakthrough: CAR-T Therapy Now Approved as Second-Line Treatment in Italy

by

For patients battling multiple myeloma, the timing of treatment is often as critical as the treatment itself. For years, the most advanced weapon in the oncological arsenal—CAR-T cell therapy—was reserved as a “last resort,” administered only after patients had failed multiple rounds of chemotherapy, proteasome inhibitors and stem cell transplants. However, a significant shift in … Read more

mRNA Vaccines and Breakthrough Drugs Offer New Hope for Pancreatic Cancer Treatment: Latest Advances in Survival and Therapy

by

Pancreatic cancer remains one of the most challenging malignancies to treat, with survival rates that have stagnated for decades despite advances in other cancers. Recent developments, however, are offering new hope as researchers explore innovative approaches ranging from targeted therapies that inhibit tumor growth to experimental mRNA-based vaccines designed to stimulate the immune system. These … Read more

Nuestra America Convoy: Breaking the US Blockade of Cuba & Solidarity Event

by

Nuestra América Convoy: International Solidarity Movement Heads to Cuba with Aid Genoa, Italy is set to host a gathering this Friday, March 20th, at 5:30 PM, as part of a broader international effort to support the Cuban people. The event, organized in collaboration with USB Liguria, CALP, and Ass.Italia Cuba, centers around the Nuestra América … Read more

New Weight Loss Pill: Oral GLP-1 Shows Promise Against Semaglutide

by

A Pill for Weight Loss? New GLP-1 Drug Shows Promise as an Oral Alternative The pursuit of effective and accessible weight loss solutions continues, and a new oral medication is generating considerable interest. Orfoglipron, a daily pill developed by Eli Lilly, is demonstrating potential as an alternative to injectable GLP-1 receptor agonists for both diabetes … Read more

The Garattini Longevity Diet: Pasta, Exercise & Simple Foods for a Longer Life

by

2026-01-28 09:21:00 di Silvia Turin Il presidente e fondatore del Mario Negri a 97 anni è l’icona di una lunga vita in salute ed esce con un nuovo libro che si intitola: «Non è mai troppo tardi» Icona di una lunga vita, 97 anni, vissuta in salute, Silvio Garattini, oncologo, farmacologo, presidente e fondatore dell’Istituto … Read more